Showing results (81-90 of 162) with videos related to
Sort By:
Pageof 17
The Journal of Cell Biology|July 1, 1982
Lipid monolayer-coated solid surfaces do not perturb the lateral motion and distribution of C3b receptors on neutrophilsD G Hafeman, L M Smith, D T Fearon, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1985
PMA induces the ligand-independent internalization of CR1 on human neutrophilsP S Changelian, R M Jack, L A Collins, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 1976
Control of the amplification convertase of complement by the plasma protein beta1HJ M Weiler, M R Daha, K F Austen, et al.The Journal of Experimental Medicine|February 1, 1978
Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparinJ M Weiler, R W Yurt, D T Fearon, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1983
Expression of C3b receptors on human be cells and myelomonocytic cells but not natural killer cellsT F Tedder, D T Fearon, G L Gartland, et al.The Journal of Experimental Medicine|November 1, 1979
Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3bM D Kazatchkine, D T Fearon, J E Silbert, et al.The New England Journal of Medicine|April 10, 1986
Neutrophil activation in thermal injury as assessed by increased expression of complement receptorsF D Moore, C Davis, M Rodrick, et al.European Journal of Immunology|February 1, 1993
V kappa gene segments rearranged in chronic lymphocytic leukemia are distributed over a large portion of the V kappa locus and do not show somatic mutationS D Wagner, L LuzzattoThe Journal of Clinical Investigation|April 1, 1982
Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosusM D Kazatchkine, D T Fearon, M D Appay, et al.Science (New York, N.Y.)|January 19, 1996
C3d of complement as a molecular adjuvant: bridging innate and acquired immunityP W Dempsey, M E Allison, S Akkaraju, et al.Pageof 17